Clinical Trials in Salt Lake City

Showing 4201-4220 of 16,694 trials

PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort

NCT02407431

The purpose of the PaTH Network IPF Clinician-Patient Partnership Cohort is to use clinical data from electronic health records (EHR) and patient reported outcomes (PRO) to answer questions of clinical importance to patients with Idiopathic Pulmonary Fibrosis, providers, and other stakeholders.

Idiopathic Pulmonary Fibrosis

University of Pittsburgh1,000 participantsStarted Mar 2015

Baltimore, Maryland, United States • Hershey, Pennsylvania, United States • Philadelphia, Pennsylvania, United States +2 more locations

COMPLETEDPhase 3< 1 mile

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

NCT03823287

This study will evaluate the efficacy, safety, durability, and pharmacokinetics of faricimab administered at intervals as specified in the protocol, compared with aflibercept once every 8 weeks (Q8W), in participants with neovascular age-related macular degeneration (nAMD).

Wet Macular Degeneration

Hoffmann-La Roche671 participantsStarted Feb 2019

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +158 more locations

PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

Find Trials by Condition in Salt Lake City

Study Evaluating the Safety and Efficacy of AR-15512

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

Wavefront-guided LASIK for Monovision Treatment of Myopic Subjects With Presbyopia

This Study Will Collect Clinical and Patient Reported Experience Data From Participants Requiring Urine Output Management Overnight in the Home Setting.

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis

Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3)

Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)

Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients

Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)

A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery

ROMTECH PortableConnect Rehabilitation Device Usage Post Unilateral Total Knee Arthroplasty (TKA)

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors

Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)

ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer